Medex Laboratories INC

Understanding Breast Cancer Risk: Genetic and Diagnostic Testing Nationwide

Understanding Breast Cancer Risk: Genetic and Diagnostic Testing Nationwide

Breast cancer remains one of the most common cancers affecting women—and increasingly, men—across the United States. Early detection and genetic risk assessment are essential for prevention and treatment. At Medex Laboratories, our advanced Hereditary Cancer Genomics (CGx) Testing empowers individuals to better understand their inherited cancer risks and take proactive steps toward health—no matter where you live in the U.S. (except California and New York).

What Is CGx (Hereditary Cancer Genomics) Testing?

CGx Testing is a specialized genetic screening that identifies inherited mutations in genes associated with hereditary cancers. Using Next-Generation Sequencing (NGS) technology, this test examines multiple genes simultaneously to provide a comprehensive overview of your genetic risk for various cancers.

Unlike diagnostic tests that detect cancer in the body, CGx testing identifies inherited genetic variants that may increase your lifetime cancer risk, helping guide early screenings and prevention strategies.

Who Should Consider CGx Testing?

You may benefit from CGx testing if you:

  • Have a personal or family history of breast, ovarian, or other cancers, especially diagnosed at a young age
  • Have had multiple cancers in your family or personal history
  • Belong to an ethnicity with high mutation prevalence (e.g., Ashkenazi Jewish)
  • Were diagnosed with breast cancer before age 50
  • Want to pursue proactive genetic risk assessment for long-term health planning

Cancer Types Screened Through CGx Testing

Medex Laboratories screens for mutations associated with a wide range of hereditary cancers, including:

  • Breast & Ovarian Cancer: BRCA1, BRCA2, PALB2, CHEK2, ATM, RAD51D
  • Colorectal & GI Cancers: APC, MLH1, MSH2, MSH6, PMS2 (linked to Lynch Syndrome, FAP)
  • Pancreatic Cancer: BRCA1/2, ATM, PALB2
  • Prostate Cancer: BRCA2, HOXB13, among others
  • Melanoma: CDKN2A and related mutations
  • Other Cancers: Endometrial, kidney, thyroid, brain, sarcoma, and more

How the Test Works

  1. Sample Collection: A simple saliva or blood sample is collected either at our lab or through your healthcare provider.
  2. DNA Sequencing: We use advanced NGS to analyze relevant genes.
  3. Analysis & Interpretation: Expert geneticists evaluate your results using AI-supported tools.
  4. Results & Counseling: Your provider receives a detailed report. We offer support to help you understand your results and plan next steps.

Key Benefits of CGx Testing

  • Early Detection: Enables earlier and more frequent cancer screenings
  • Tailored Treatments: Supports selection of personalized therapies (e.g., PARP inhibitors for BRCA mutations)
  • Family Risk Management: Helps relatives understand their risk and consider screening
  • Access to Clinical Trials: Opens doors to experimental treatments when applicable
  • Informed Medical Choices: Empowers you to consider preventive measures like surgery, medication, or lifestyle changes

Interpreting Your Results

  • Pathogenic Variant Detected: High risk for hereditary cancer; clinical action recommended
  • Likely Pathogenic: Further evaluation advised
  • Variant of Uncertain Significance (VUS): Needs more research; family testing may help clarify
  • No Pathogenic Variant Found: Lower genetic risk detected, but routine screenings may still be advised

Nationwide Access & Insurance Coverage

Medex Laboratories proudly processes genetic samples from across the United States, except California and New York.
Many insurance plans, including Medicare and private carriers, cover CGx testing for eligible individuals. Our team can help:

  • Verify coverage
  • Handle pre-authorizations
  • Provide financial support options if needed

Why Choose Medex Laboratories?

  • Comprehensive Panels: Includes all major hereditary cancer genes
  • CLIA-Certified, CAP-Accredited: Ensuring accuracy and reliability
  • Results Within 2–4 Weeks
  • Genetic Counseling Support
  • Nationwide Reach (excl. CA & NY)

Take Control of Your Breast Cancer Risk Today

Understanding your genetic risk is a powerful first step toward prevention and peace of mind. Whether for yourself or your family, CGx testing at Medex Laboratories helps you make smarter, personalized healthcare decisions.

Schedule your consultation or testing appointment today—we’re here to support you across the U.S., with the exception of California and New York due to state-specific regulations.

Add a Comment

Your email address will not be published.